Last updated on January 2017

A Phase 4, Double-Blind, Randomized, Placebo-Controllled, Parallel Group, Multi-Center Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects with Overactive Bladder (OAB)


Brief description of study

A Phase 4, Double-Blind, Randomized, Placebo-Controllled, Parallel Group, Multi-Center Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects with Overactive Bladder (OAB)

Detailed Study Description

Receive Mirabegron (FDA approved) or Placebo (Sugar Pill) as treatment for Overactive Bladder (OAB)

Clinical Study Identifier: TX147190

Contact Investigators or Research Sites near you

Start Over

Barbara G. Melo, CRC

Clinical Research of South Florida
Coral Gables, FL USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.